A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors - ScienceDirect
Serum IL-6 and TNF-α levels of mice with DSS-induced colitis treated... | Download Scientific Diagram
Schematic model of IL-6/STAT3 pathway in inflammatory bowel disease.... | Download Scientific Diagram
Biotin Supplementation Ameliorates Murine Colitis by Preventing NF-κB Activation - ScienceDirect
Immunopathogenesis of IBD: current state of the art | Nature Reviews Gastroenterology & Hepatology
Biological characteristics of IL-6 and related intestinal diseases
Frontiers | New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease - ScienceDirect
New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology | Nature Reviews Gastroenterology & Hepatology
Il‐6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance - Mudter - 2007 - Inflammatory Bowel Diseases - Wiley Online Library
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease - ScienceDirect
Frontiers | IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology
Compartmentalized Response of IL-6/STAT3 Signaling in the Colonic Mucosa Mediates Colitis Development | The Journal of Immunology
Biological characteristics of IL-6 and related intestinal diseases
I-Mab's IL-6 drug hits goal in ulcerative colitis phase 2 | Fierce Biotech
Frontiers | IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
Compartmentalized Response of IL-6/STAT3 Signaling in the Colonic Mucosa Mediates Colitis Development
Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway | BMC Complementary Medicine and Therapies | Full Text
Antibody signatures in inflammatory bowel disease: current developments and future applications: Trends in Molecular Medicine
Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study | PLOS ONE
Translating IL-6 biology into effective treatments | Nature Reviews Rheumatology
The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target: Molecular Therapy
Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine
Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn's Disease and Ulcerative Colitis - ScienceDirect
